Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.
Price
Target price
€254.60

€254.60

1.560%
3.9
1.560%
-

-

 
11:24 / Tradegate WKN: 870980 / Symbol: RGEN / Name: Repligen Corp / Stock / Pharmaceuticals / Mid Cap /
Latest predictions
03.08.21
21.24%
buy
08.07.21
45.53%
buy
€155.00
12.01.20
190.97%
buy
Best running prediction
€155.00
12.01.20
190.97%
buy
Your prediction

Repligen Corp. Stock

Repligen Corp. gained 1.560% today.
Our community is currently high on Repligen Corp. with 3 Buy predictions and 0 Sell predictions.
Criterium "Worthwhile Investment for the next years" is seen as the biggest plus for Repligen Corp. stock. Negative votes have not been in the majority for any criteria for this stock

Pros and Cons of Repligen Corp. in the next few years

Pros
1
Could be worthwhile Investment >10% per year
Cons
0
-

Performance of Repligen Corp. vs. its peers

Security Change(%) 1w 1m 1y YTD 3y 5y
Repligen Corp. 1.560% 0.683% 15.317% 97.479% 62.581% - -
Catalent Inc. 0.000% -2.479% 14.563% 65.035% 40.476% 233.522% 464.593%
Amicus Therapeutics Inc. -1.060% -2.073% 6.180% -19.231% -48.919% - -
Opko Health Inc. 0.060% -2.128% -5.762% 10.885% -8.515% -21.702% -67.801%

Other discussions about Repligen Corp. Stock

New thread Forum